Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Archive

Psyence wins ISO certification from British Standards Institute for psilocybin production facility

Psyence wins ISO certification from British Standards Institute for psilocybin production facility

Psyence Group Inc (CSE:PSYG)'s Yasin Khan tells Proactive the life science biotechnology company's psilocybin production facility has officially received International Organization for Standardization (ISO) 22000:2018 certification through the British Standards Institute (BSI). ISO 22000 is a globally accepted international standard that specifies the requirements for food safety management systems. Psyence’s facility, which is federally licensed to cultivate and export Psilocybin mushrooms for the legal medical and research markets, is based in Southern Africa and has been operational since January 2021.

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK